{
    "clinical_study": {
        "@rank": "166603", 
        "arm_group": [
            {
                "arm_group_label": "Buccal misoprostol", 
                "arm_group_type": "Active Comparator", 
                "description": "400 \u00b5g buccal misoprostol per 3 hours"
            }, 
            {
                "arm_group_label": "vaginal misoprostol", 
                "arm_group_type": "Active Comparator", 
                "description": "400 \u00b5g vaginal misoprostol per 3 hours"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the efficacy of 400 \u00b5g  vaginal misoprostol  per 3\n      hours to 400 \u00b5g buccal misoprostol per 3 hours in second trimester termination of viable\n      pregnancy"
        }, 
        "brief_title": "Misoprostol for Second Trimester Termination of Pregnancy", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Abortion, Induced", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  gestational age between 12-24 weeks\n\n          -  live fetus\n\n          -  singleton pregnancy\n\n          -  Bishop score <5\n\n          -  no uterine contraction\n\n        Exclusion Criteria:\n\n          -  prostaglandin allergy\n\n          -  a scar in uterus\n\n          -  uterine abnormality\n\n          -  premature rupture of membranes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02048098", 
            "org_study_id": "atauni9"
        }, 
        "intervention": [
            {
                "arm_group_label": "vaginal misoprostol", 
                "description": "400 \u00b5g vaginal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 \u00b5g vaginal misoprostol per 3 hours up to 6 doses  will be administered. If abortion  had not occured in 48 hour after the start of the study  it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.", 
                "intervention_name": "Vaginal misoprostol", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }, 
            {
                "arm_group_label": "Buccal misoprostol", 
                "description": "400 \u00b5g buccal misoprostol per 3 hours up to 6 doses. The treatment will be withold if the patient has strong uterine contractions. If abortion had not occured in 24 hour after the start of the study a second course of 400 \u00b5g buccal misoprostol per 3 hours up to 6 doses  will be administered. If abortion  had not occured in 48 hour after the start of the study  it will be considered treatment failure and patient will be offered another induction/delivery method or to continue protocol.", 
                "intervention_name": "Buccal misoprostol", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Misoprostol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "misoprostol", 
            "Labor, Induced", 
            "Pregnancy Trimester, Second", 
            "Abortion, Induced"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Erzurum", 
                    "country": "Turkey", 
                    "zip": "25240"
                }, 
                "name": "Ataturk Universitesi Ara\u015ft\u0131rma Hastanesi"
            }, 
            "investigator": {
                "last_name": "Rag\u0131p A Al, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Comparison Between Vaginal Misoprostol vs. Buccal Misoprostol For Second Trimester Termination of Pregnancy", 
        "other_outcome": [
            {
                "measure": "total misoprostol dose", 
                "safety_issue": "No", 
                "time_frame": "48 hours"
            }, 
            {
                "measure": "difference in hematocrit measured at entry of the study  and after delivery/abortion", 
                "safety_issue": "No", 
                "time_frame": "at recruitment and 24 hour after abortion"
            }, 
            {
                "description": "includes, but not limited blood, transfusions, laparatomy, nausea, vomiting, fever, genital tract injury", 
                "measure": "maternal complications", 
                "safety_issue": "No", 
                "time_frame": "one weeks"
            }
        ], 
        "overall_contact": {
            "email": "atakanal@gmail.com", 
            "last_name": "Rag\u0131p A Al, MD", 
            "phone": "00905324861433"
        }, 
        "overall_official": [
            {
                "affiliation": "Ataturk University Faculty of Medicine", 
                "last_name": "Rag\u0131p A AL, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ataturk University Faculty of Medicine", 
                "last_name": "\u00d6mer E Yap\u00e7a, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time elapsed between administration of the first misoprostol dose until expulsion of the fetus", 
            "measure": "Induction to fetal expulsion interval", 
            "safety_issue": "No", 
            "time_frame": "15 minutes after fetus delivered"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02048098"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ataturk University", 
            "investigator_full_name": "Rag\u0131p Atakan Al", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Delivery within 24 hours", 
                "safety_issue": "No", 
                "time_frame": "24 hour"
            }, 
            {
                "measure": "Delivery within 48 hours", 
                "safety_issue": "No", 
                "time_frame": "48 hours"
            }, 
            {
                "description": "the patients who did not delivered within 48 hours will considered as failed induction and will be offered another method of induction/delivery or to continue same protocol.", 
                "measure": "Use of additional interventions", 
                "safety_issue": "No", 
                "time_frame": "One week"
            }, 
            {
                "description": "Perceived pain will be measured by Face Pain Scale-Revised", 
                "measure": "Perceived pain before induction and after abortion completed", 
                "safety_issue": "No", 
                "time_frame": "within 1 hour after randomisation and after 12 hour after complete abortion/placenta removed"
            }, 
            {
                "measure": "Rate of complete abortion", 
                "safety_issue": "No", 
                "time_frame": "12 hour after fetus and placenta removed"
            }
        ], 
        "source": "Ataturk University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ataturk University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}